Gedeon Richter files biosimilar RoActemra with European agency
- ByInvesting.com-
Investing.com -- Gedeon Richter has submitted a biosimilar version of Roche’s RoActemra (tocilizumab) to the European Medicines...
Last | High | Low | |||||
---|---|---|---|---|---|---|---|
26,850.0 | 27,490.0 | 26,300.0 | -890.0 | -3.21% | 636.54K | ||
3,112.0 | 3,144.0 | 3,082.0 | +14.0 | +0.45% | 750.59K | ||
10,310.0 | 10,400.0 | 10,150.0 | +10.0 | +0.10% | 254.51K | ||
1,730.0 | 1,768.0 | 1,704.0 | -36.0 | -2.04% | 1.33M | ||
1,465.0 | 1,490.0 | 1,465.0 | -40.0 | -2.66% | 5.51K | ||
7,740.0 | 7,900.0 | 7,580.0 | -140.0 | -1.78% | 11.07K | ||
56.800 | 59.500 | 55.900 | -1.200 | -2.07% | 144.43K | ||
365.0 | 374.0 | 364.0 | -6.0 | -1.62% | 132.38K | ||
705.0 | 720.0 | 690.0 | -1.0 | -0.14% | 130.22K | ||
12.6 | 12.7 | 12.6 | -0.1 | -0.79% | 235 | ||
558.00 | 569.00 | 550.00 | -11.00 | -1.93% | 152.05K | ||
1,764.0 | 1,780.0 | 1,710.0 | -8.0 | -0.45% | 119.63K | ||
2,410.0 | 2,480.0 | 2,410.0 | -40.0 | -1.63% | 7.64K | ||
5,480.0 | 5,600.0 | 5,480.0 | -120.0 | -2.14% | 5.34K | ||
4,490.00 | 4,550.00 | 4,380.00 | -10.00 | -0.22% | 3.8K | ||
156.50 | 160.00 | 154.00 | -3.50 | -2.19% | 149.54K |
Investing.com -- Gedeon Richter has submitted a biosimilar version of Roche’s RoActemra (tocilizumab) to the European Medicines...
Investing.com -- Shares of MOL Group (BUD:MOL) fell by 1% following the release of its fourth-quarter results, which showed Clean...
By Chibuike Oguh and Marc Jones NEW YORK/LONDON (Reuters) - Global equity markets fell while gold prices surged on Thursday, with...
No Earning Reports have been scheduled